Dr. Evan James Trapana, MD

Dr. Trapana practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Trapana's NPI, 1639610983, was assigned on March 19, 2017. Dr. Trapana graduated from University of Miami, Miller School of Medicine in 2017. Dr. Trapana holds Florida license ME154370.

Dr. Trapana's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Trapana's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Trapana is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Trapana to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trapana practices, 3 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Trapana's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dmand AI has Dr. Trapana's licenses on file in 2 states: Florida and California.

Dmand AI lists arthritis, pelvic and hip fracture, scoliosis and spinal fusion among the conditions Dr. Trapana treats.

CMS data shows 108 Medicare services from Dr. Trapana across 3 procedure codes in 2024, all of them office visits, for 95 Medicare patients. Medicare paid $9,739 for them.

CMS counts 95 Medicare patients who saw Dr. Trapana in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have arthritis, and 75% have high blood pressure. 51% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trapana's median patient age at 68, with 54% women.

In 2024, Dr. Trapana wrote 218 Medicare Part D claims for 75 patients. 100% of them were for generic drugs. CMS names the drug for 178 of them, across 6 drugs with 11 or more claims each, at $2,362 in total drug cost. In 2023, CMS named 101 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Trapana for performance year 2024, reported as part of a group. Dr. Trapana accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Trapana as offering telehealth. CMS counts 49 procedures of spinal fusion by Dr. Trapana, more than 55% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Trapana, published from 2018 to 2025. Dr. Trapana's most frequent co-authors are Spencer W. Barnhill, Amiethab Aiyer, MD and Dhanur Damodar, MD.

CMS Open Payments shows 139 general payments to Dr. Trapana from 16 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 49% of the total. Kuros Biosciences USA, Inc paid the most, $5,868.

Dr. Trapana graduated from University of Miami, Miller School of Medicine in 2017. Dr. Trapana is a member of AAOS.

Dr. Trapana is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.